Ms. Petrovic contributes decades of experience as an executive in the medical device industry, where she is well-known as a visionary and inspiring leader who has dedicated her career to improving care for patients, while bringing tremendous value to the clinical community. She contributes extensive industry leadership experience and first-hand oversight of the successful launch of impact-focused technologies and medical devices, which have positively impacted business growth. Executive Leadership; Pipeline Development/Commercialization: During Ms. Petrovic s tenure as Chief Executive Officer of Insulet Corporation (Nasdaq: PODD), she spearheaded a period of strong financial growth as the company shifted to pharmacy and launched its flagship innovation, the Omnipod 5. She also contributes deep sales and marketing experience to the Board from her previous role as Chief Executive Officer at Clinical Innovations and several leadership positions at Hologic (Nasdaq: HOLX). Diagnostics/Medical Device and Technology; Government, Regulatory, and Compliance: Obtained from her career of developing deep relationships within the healthcare industry, particularly within diagnostics and screening, which has been critical in her oversight of the full commercialization lifespan of medical device products, including the critical regulatory approval stage. Talent Management; Finance, Corporate Strategy, and M&A : Acquired valuable talent acquisition and management experience from her numerous leadership positions of increasing responsibility at both Insulet Corporation and Hologic. While serving as Chief Executive Officer of Insulet Corporation, her responsibilities included active ultimate oversight of the finance and corporate strategy functions, which resulted in the company s growth from $2 billion to over $20 billion in market capitalization. CAREER HIGHLIGHTS Insulet Corporation , (Nasdaq: PODD) innovative medical device company Board Member and Advisor (2018-2024) President and Chief Executive Officer (2019-2022) President and Chief Operating Officer (2016-2018) President, Insulet Diabetes Products (2016) Chief Commercial Officer (2015-2016) Clinical Innovations, LLC developer and manufacturer of medical devices and diagnostics for women s health President and Chief Executive Officer (2013-2015) Hologic, Inc , (Nasdaq: HOLX) medical technology company Vice President and General Manager, GYN Surgical Products (2012-2013) Vice President, Global Surgical Marketing (2010-2012) Business Director (2008-2010) Cytyc Corporation (acquired by Hologic, Inc. in 2007) biotechnology company focused on women s health Various leadership roles, including in sales (2000-2007) EDUCATION B.S., Biology, University of Wisconsin-Milwaukee